ARCHIVES

ASCO and CAP Issue Guideline To Improve HER2 Testing

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

NCI Cooperative Group, Cancer Center Trials Listed

March 28, 2008

NCI, NCAB Consider Moving Basic Science Centers Out Core Grant Pool, Into Research Programs

February 10, 1989

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Senate Democrats Include $1 Billion Boost To NIH In Economic Stimulus Package.

November 21, 2008